CAMBRIDGE, Mass., Feb. 1, 2018 /CNW/ -- Nitto Denko Avecia, Inc. (Avecia), a leader in oligonucleotide API (active pharmaceutical ingredient) manufacturing, announced today the opening of a new corporate office in Cambridge, MA, to support its operations and corporate development activities, and to be more accessible to clients.
Detlef Rethage, President of Avecia stated, "The new office, located in Kendall Square, the hotspot for oligonucleotides-based therapeutics, brings Avecia, its subsidiary Nitto Avecia Pharma Services, and all other Nitto Life Sciences activities closer to its existing partners in the US. This is just another step the organization is taking in support of Nitto's corporate credo, 'NITTO EVERYWHERE'."
Avecia will be attending the 10th Annual AsiaTIDES conference in Kyoto, Japan, February 27-March 1, 2018. To learn more about Avecia's continuous growth, please visit us at booth A-5 or learn more at www.Avecia.com.
ABOUT NITTO AVECIA, INC.
Nitto Avecia, Inc. is a recognized leader in manufacturing and development services of oligonucleotides-based therapeutics with facilities located in Milford, MA.; Marlboro, MA.; and Cincinnati, OH offering services for DNA, RNA and other oligonucleotides-based therapeutics from milligram scale at pre-clinical stage to 1000kg + post commercial launch. More information: www.Avecia.com. Nitto Avecia is a proud member of the Nitto Group. More information: www.Nitto.com
ABOUT NITTO AVECIA PHARMA SERVICES, INC.
Nitto Avecia Pharma Services is your single solution for premier contract development and manufacturing services. Nitto Avecia Pharma Services supports the pharmaceutical, biopharmaceutical, and medical device industries with a complete package of CGMP services including pre-formulation/formulation, parenteral manufacturing, analytical development, biopharmaceutical development, structural chemistry, analytical chemistry, microbiology, stability storage and drug delivery device testing. With three state-of-the-art facilities located on one campus in Irvine, CA. Learn more at www.aveciapharma.com.
SOURCE Nitto Denko Avecia, Inc.
For further information: Detlef Rethage, President, Nitto Avecia, Inc., (508) 532-2500, http://www.avecia.com